The University of Chicago Header Logo

Connection

Ezra Cohen to Pharmacogenetics

Back to Details
This is a "connection" page, showing publications Ezra Cohen has written about Pharmacogenetics.
Ezra Cohen
Connection Strength
0.314
Pharmacogenetics
  1. Phase II efficacy and pharmacogenomic study of Selumetinib (AZD6244; ARRY-142886) in iodine-131 refractory papillary thyroid carcinoma with or without follicular elements. Clin Cancer Res. 2012 Apr 01; 18(7):2056-65.
    View in: PubMed
    Score: 0.314
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.